Usman Siddiqui
Neurology · Lawrenceburg, INNPI 1114927712
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 76.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $8,758 and has fallen 98.4% since, to $142 in 2025.
Across 77 payments — averaging $147.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Biogen$401
- AbbVie$331
- Amgen$324
- Acadia Pharmaceuticals Inc$297
- AstraZeneca$236
- plus $1K from 14 others
What the payments were for
- Consulting fees$6,36656%
- Travel & lodging$2,20719%
- Food & beverage$2,71024%
- Education$591%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $8,672 |
| Biogen | 4 | $401 |
| AbbVie(2 entities) | 7 | $331 |
| Amgen(2 entities) | 3 | $324 |
| Acadia Pharmaceuticals Inc | 7 | $297 |
| AstraZeneca | 2 | $236 |
| Sunovion Pharmaceuticals Inc. | 25 | $204 |
| Greenwich Biosciences, Inc. | 3 | $142 |
| SK Life Science, Inc. | 1 | $122 |
| Biohaven Pharmaceuticals, Inc. | 1 | $120 |
| Idorsia Pharmaceuticals US Inc | 1 | $89 |
| Bard Peripheral Vascular, Inc. | 1 | $84 |
| Reflow Medical Inc | 1 | $75 |
| Akcea Therapeutics, Inc. | 1 | $72 |
| Boston Scientific | 1 | $67 |
| Sumitomo Pharma America, Inc. | 4 | $50 |
| GE HealthCare | 1 | $23 |
| Medtronic | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
| Neuronetics, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$8,525
- NUPLAZID$269
- Epidiolex$125
- UPLIZNA$124
- XCOPRI$122
- NURTEC ODT$120
- UBRELVY$119
- Repatha$115
How this compares
$11,341 in reported general payments places this provider in the 75th percentile of 308 neurology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 16 | $1,500 |
| Gabapentin | 101 | $1,308 |
| Ropinirole Hcl | 79 | $820 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $718 |
| Levetiracetam | 20 | $674 |
| Topiramate | 50 | $557 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $490 |
| Tizanidine Hcl | 29 | $463 |
| Pregabalin | 12 | $434 |
| Doxepin Hcl | 12 | $408 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $390 |
| Tramadol Hcl | 33 | $324 |
| Verapamil ErVerapamil Hcl | 11 | $275 |
| Promethazine Hcl | 29 | $268 |
| Memantine Hcl | 22 | $246 |
Paid to pharmacies, not to this prescriber.
Other neurology in Lawrenceburg
- William ConteMerrillville$1.2M
- Anthony SimchakLafayette$720K
- Mark JanickiLebanon$573K
- Ajay GuptaFort Wayne$411K
- Roderick WarrenEvansville$296K
- Ender AkanMunster$296K
- Christopher WilsonAvon$283K
- Marlene BultemeyerFort Wayne$277K
- Jerry SmarttCarmel$254K
- Andrea HallerFort Wayne$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.